ABVX
Price
$124.92
Change
+$0.59 (+0.47%)
Updated
Jul 31 closing price
Capitalization
10.68B
49 days until earnings call
Intraday BUY SELL Signals
FULC
Price
$3.58
Change
-$0.14 (-3.76%)
Updated
Jul 31 closing price
Capitalization
273.14M
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABVX vs FULC

ABVX vs FULC Comparison Chart in %
View a ticker or compare two or three
VS
ABVX vs. FULC commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Buy and FULC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (ABVX: $124.92 vs. FULC: $3.58)
Brand notoriety: ABVX and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 24% vs. FULC: 94%
Market capitalization -- ABVX: $10.68B vs. FULC: $273.14M
ABVX [@Biotechnology] is valued at $10.68B. FULC’s [@Biotechnology] market capitalization is $273.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABVX and FULC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 7 TA indicator(s) are bullish while FULC’s TA Score has 2 bullish TA indicator(s).

  • ABVX’s TA Score: 7 bullish, 4 bearish.
  • FULC’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, ABVX is a better buy in the short-term than FULC.

Price Growth

ABVX (@Biotechnology) experienced а -0.62% price change this week, while FULC (@Biotechnology) price change was -3.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

ABVX is expected to report earnings on Sep 21, 2026.

FULC is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($10.7B) has a higher market cap than FULC($273M). ABVX YTD gains are higher at: -7.367 vs. FULC (-68.347). FULC has higher annual earnings (EBITDA): -85.4M vs. ABVX (-298.47M). ABVX has more cash in the bank: 492M vs. FULC (319M). ABVX has less debt than FULC: ABVX (1.45M) vs FULC (5.28M). ABVX (0) and FULC (0) have equivalent revenues.
ABVXFULCABVX / FULC
Capitalization10.7B273M3,919%
EBITDA-298.47M-85.4M350%
Gain YTD-7.367-68.34711%
P/E RatioN/AN/A-
Revenue00-
Total Cash492M319M154%
Total Debt1.45M5.28M27%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXFULC
RSI
ODDS (%)
Bearish Trend 4 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 12 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signal:
Gain/Loss:
FULC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACGLN16.450.10
+0.58%
Arch Capital Group Ltd
WSE12.00-0.06
-0.50%
Wise Group Plc
ANPA4.14-0.04
-0.96%
Rich Sparkle Holdings Limited
PBFS17.22-0.41
-2.33%
Pioneer Bancorp
EMAT3.66-0.76
-17.19%
Evolution Metals & Technologies Corp.

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with IMNN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+0.47%
IMNN - ABVX
58%
Loosely correlated
-0.62%
FULC - ABVX
53%
Loosely correlated
-3.76%
HRTX - ABVX
49%
Loosely correlated
-0.24%
XENE - ABVX
38%
Loosely correlated
-2.37%
IRON - ABVX
35%
Loosely correlated
-2.79%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with HRTX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-3.76%
HRTX - FULC
54%
Loosely correlated
-0.24%
ABVX - FULC
53%
Loosely correlated
+0.47%
SLS - FULC
48%
Loosely correlated
-2.72%
KYMR - FULC
42%
Loosely correlated
-3.37%
GPCR - FULC
41%
Loosely correlated
-2.89%
More